ALFA Filings
Every announcement, straight from the exchange
Every Ind-Swift Laboratories capital structure change announcement on NSE and BSE, newest first, each with its own page.
Time
6 announcements with these filters
Ind-Swift Laboratories allotted 14,00,000 equity shares upon conversion of warrants at Rs. 196 each. The allotment follows a previously approved preferential issue.
Ind-Swift Laboratories allotted 14 lakh equity shares upon converting warrants for Essix Biosciences Limited, receiving ₹20.58 Crore. This increases the company's paid-up equity share capital.
Promoter entity Essix Biosciences Limited acquired 70,00,000 fully convertible warrants of Ind-Swift Laboratories via a preferential allotment.
Ind-Swift Laboratories allotted 70 lakh fully convertible warrants at Rs. 196 each, totaling Rs. 137.2 Crore. This preferential issue will augment capital upon warrant conversion.
Ind-Swift Laboratories Limited allotted 70,00,000 fully convertible warrants to Essix Biosciences Limited on a preferential basis. The company received Rs. 34.30 Crore as upfront payment.
Ind-Swift Laboratories' Preferential Issue Committee approved a revised issue price of Rs. 196 per warrant. The pricing follows SEBI ICDR regulations and a revised valuation report.